Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,04 USD | +2,26% | -3,25% | -12,14% |
26/03 | SAGE THERAPEUTICS, INC. : JPMorgan Chase herhaalt koopadvies | ZM |
15/02 | SAGE THERAPEUTICS, INC. : Deutsche Bank Securities is neutraal gestemd over het aandeel | ZM |
Omzet 2024 * | 34,65 mln. 32,11 mln. | Omzet 2025 * | 127 mln. 117 mln. | Marktkapitalisatie | 1,14 mld. 1,06 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -384 mln. -356 mln. | Nettowinst (verlies) 2025 * | -312 mln. -289 mln. | EV/omzet 2024 * | 18,9 x |
Nettoliquiditeiten 2024 * | 491 mln. 455 mln. | Nettoliquiditeiten 2025 * | 372 mln. 345 mln. | EV/omzet 2025 * | 6,1 x |
K/w-verhouding 2024 * |
-3,04
x | K/w-verhouding 2025 * |
-3,92
x | Werknemers | 487 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,44% |
Recentste transcriptie over Sage Therapeutics, Inc.
1 dag | +2,26% | ||
1 week | -3,25% | ||
Lopende maand | -11,36% | ||
1 maand | -16,16% | ||
3 maanden | -14,47% | ||
6 maanden | -10,65% | ||
Lopend jaar | -12,14% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 01-10-20 |
Steven Paul
FOU | Founder | 73 | 16-04-10 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 01-03-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 14-08-13 |
Steven Paul
FOU | Founder | 73 | 16-04-10 |
Barry Greene
CEO | Chief Executive Officer | 60 | 01-10-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.13% | 17 M€ | -0,46% | ||
0.21% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 19,04 | +2,26% | 551 465 |
26-03-24 | 18,62 | -0,37% | 830 173 |
25-03-24 | 18,69 | -2,76% | 530 933 |
22-03-24 | 19,22 | -3,76% | 447 310 |
21-03-24 | 19,97 | +1,47% | 791 236 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,14% | 1,14 mld. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,80% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |